drugset / Trial / NCT01297569
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to explore a more individualized treatment regime based on achievement of disease stability to define a personal optimal treatment interval with ranibizumab in patients with visual impairment due to diabetic macular edema.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | — | — |